{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:14:27Z","timestamp":1768569267913,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.msard.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:50:49Z","timestamp":1549828249000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-0349","authenticated-orcid":false,"given":"Anas","family":"Bennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"El Otmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Benkirane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilham","family":"Harrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouchra","family":"El Moutawakil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Abdoh","family":"Rafai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilham","family":"Slassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2B","key":"10.1016\/j.msard.2019.02.012_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1590\/S0004-282X2008000300001","article-title":"Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica","volume":"66","author":"Adoni","year":"2008","journal-title":"Arq. Neuropsiquiatr."},{"issue":"10","key":"10.1016\/j.msard.2019.02.012_bib0002","first-page":"B4730","article-title":"Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO)","volume":"60","author":"Asgari","year":"2013","journal-title":"Dan. Med. J."},{"issue":"18","key":"10.1016\/j.msard.2019.02.012_bib0003","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.msard.2019.02.012_bib0004","first-page":"438","article-title":"Association between neuromyelitis optica spectrum disorders and Beh\u00e7et's disease in 2 Moroccan patients","volume":"23","author":"Bennis","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2019.02.012_bib0043","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2019.02.012_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tracli.2006.12.003","article-title":"HLA-A, -B, -DR and -DQ allele and haplotype frequencies in the Moroccan population: A general population study","volume":"13","author":"Brick","year":"2006","journal-title":"Transfus. Clin. Biol."},{"issue":"3","key":"10.1016\/j.msard.2019.02.012_bib0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders\u2014An update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"8\u20139","key":"10.1016\/j.msard.2019.02.012_bib0007","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurol.2009.02.012","article-title":"Descriptive epidemiology of neuromyelitis optica in the Caribbean basin","volume":"165","author":"Cabre","year":"2009","journal-title":"Rev. Neurol. (Paris)"},{"issue":"4","key":"10.1016\/j.msard.2019.02.012_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2019.02.012_bib0009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1468-1331.2008.02376.x","article-title":"Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese","volume":"16","author":"Chan","year":"2009","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2019.02.012_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: A multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2019.02.012_bib0011","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jamaneurol.2016.1637","article-title":"Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis","volume":"73","author":"Damato","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2019.02.012_bib0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.msard.2015.12.005","article-title":"Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou","volume":"6","author":"Daoudi","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2019.02.012_bib0013","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/0004-282x20160193","article-title":"Neuromyelitis optica: phenotypic characteristics in a Brazilian case series","volume":"75","author":"Del Negro","year":"2017","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.msard.2019.02.012_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2015.04.001","article-title":"Neuromyelitis optica in Portugal (NEMIPORT)\u2014A multicentre study","volume":"134","author":"Domingos","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"12 Pt 1","key":"10.1016\/j.msard.2019.02.012_bib0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0035-3787(05)85192-6","article-title":"Devic's neuromyelitis optica in Morocco. A study of 9-cases","volume":"161","author":"El Otmani","year":"2005","journal-title":"Rev. Neurol. (Paris)"},{"issue":"1 Pt 1","key":"10.1016\/j.msard.2019.02.012_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0761-8425(05)85445-2","article-title":"Devic's optic neuromyelitis and pulmonary tuberculosis","volume":"22","author":"El Otmani","year":"2005","journal-title":"Rev. Mal. Respir."},{"issue":"4","key":"10.1016\/j.msard.2019.02.012_bib0017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1352458512457720","article-title":"Neuropathic pruritus (itch) in neuromyelitis optica","volume":"19","author":"Elsone","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2019.02.012_bib0044","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.msard.2017.01.004","article-title":"Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study","volume":"12","author":"Eskandarieh","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2019.02.012_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msard.2017.01.011","article-title":"Pruritus may be a common symptom related to neuromyelitis optica spectrum disorders","volume":"13","author":"He","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2019.02.012_bib0019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"19","key":"10.1016\/j.msard.2019.02.012_bib0020","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.msard.2019.02.012_bib0021","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2019.02.012_bib0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/1352458513507822","article-title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","volume":"20","author":"Kremer","year":"2014","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2019.02.012_bib0023","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.25.9.845","article-title":"Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases","volume":"25","author":"Kuroiwa","year":"1975","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2019.02.012_bib0024","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2990.2010.01105.x","article-title":"Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology","volume":"36","author":"Lee","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"9451","key":"10.1016\/j.msard.2019.02.012_bib0025","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2019.02.012_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-14-33","article-title":"Association between neuromyelitis optica and tuberculosis in a Chinese population","volume":"14","author":"Li","year":"2014","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.msard.2019.02.012_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mus.21197","article-title":"Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica","volume":"39","author":"McKeon","year":"2009","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.msard.2019.02.012_bib0028","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: A multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2019.02.012_bib0029","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: Comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2019.02.012_bib0030","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1352458516665497","article-title":"Is pruritus an indicator of aquaporin-positive neuromyelitis optica?","volume":"23","author":"Netravathi","year":"2017","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2019.02.012_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127757","article-title":"Central Nervous system idiopathic inflammatory demyelinating disorders in South Americans: A descriptive, multicenter, cross-sectional study","volume":"10","author":"Papais-Alvarenga","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.msard.2019.02.012_bib0045","first-page":"S37","article-title":"Devic\u2019s neuromyelitis optica (NMO) and multiple sclerosis (MS): clinical and epidemiologic findings in an MS center in Argentina","volume":"8","author":"Patrucco","year":"2002","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2019.02.012_bib0032","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2019.02.012_bib0033","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2019.02.012_bib0034","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.02.012_bib0035","first-page":"196","article-title":"Devic-like syndrome in the course of pulmonary tuberculosis","volume":"110","author":"Rafai","year":"2010","journal-title":"Acta Neurol. Belg."},{"issue":"5","key":"10.1016\/j.msard.2019.02.012_bib0036","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic's disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2019.02.012_bib0037","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2018.08.014","article-title":"Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta","volume":"324","author":"Salama","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2019.02.012_bib0038","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1590\/S0004-282X2011000600019","article-title":"A typical presentations of neuromyelitis optica","volume":"69","author":"Sato","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.msard.2019.02.012_bib0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2019.02.012_bib0040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2019.02.012_bib0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2019.02.012_bib0042","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jns.2016.09.035","article-title":"Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study","volume":"370","author":"Xu","year":"2016","journal-title":"J. Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819300689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819300689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:43:27Z","timestamp":1761900207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819300689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":45,"alternative-id":["S2211034819300689"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.02.012","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}